Several GBM antigens represent reasonable targets for CAR T cell development, such as EGFRvIII (204, 205), IL13 receptor subunit alpha 2 (IL13Ra2) (96, 206, 207) or Her2 (208–210). The gene discussed is IL13RA2; the disease is glioblastoma.